INTRODUCTION {#S1}
============

The Wnt/β-catenin signaling pathway is a key regulator of growth and development, driving both cellular proliferation and morphogenetic changes in a wide array of organisms ([@R19]; [@R23]; [@R26]; [@R29]; [@R45]). This pathway also plays a critical role in mediating ongoing tissue maintenance in many organs, including the intestine, liver, brain, and adrenal cortex ([@R14]; [@R36]; [@R51]). Consistent with this role, constitutive activation of this pathway, either following somatic gain-of-function (GOF) mutations in β-catenin or loss-of-function (LOF) mutations in key negative regulators, such as APC (adenomatous polyposis coli) or in the transmembrane E3 ubiquitin ligase ZNRF3 (zinc and ring finger 3), leads to tissue hyperplasia and ultimately to neoplastic transformation ([@R36]; [@R38]). Whether the intrinsic proliferative capacity of a given tissue contributes to this hyperplastic response is unclear.

The adrenal cortex continuously turns over, renewing approximately every 1--3 months, despite having a relatively low proliferation rate ([@R9]; [@R56]). It is composed of distinct concentric zones that develop postnatally ([@R37]; [@R52]). The outermost layer, the zona Glomerulosa (zG) consists of aldosterone-producing cells, which give rise to the innermost layer, the glucocorticoid-producing zona Fasciculata (zF) through the process of zonal transdifferentiation and centripetal migration ([@R18]; [@R37]). Recent studies have shown that high levels of Wnt/β-catenin signaling within the zG contribute to the determination of zonal identity by both positively regulating the transcription of zG-specific genes (e.g., *Cyp11b2*, *Aldosterone Synthase*) and negatively regulating zF-specific genes (e.g., *Cyp11b1*, *11β-hydroxylase*) ([@R5]; [@R6], [@R7]; [@R14]; [@R22]; [@R25]; [@R37]; [@R51]; [@R53]).

Constitutive activation of the Wnt/β-catenin signaling pathway has been linked to adrenocortical hyperplasia and neoplastic transformation ([@R2]; [@R3]; [@R5]; [@R7]; [@R50]; [@R54]; [@R58]). In fact, β-catenin GOF mutations and LOF mutations in APC and ZNRF3 are among the most common somatic changes in adrenocortical carcinoma ([@R3]; [@R28]; [@R39]; [@R50]; [@R58]). However, the cellular mechanisms responsible for adrenal hyperplasia following activation of this pathway remain unknown. To address this, we specifically targeted zG cells with a somatic β-catenin GOF mutation in mice. Our data reveal that the progressive hyperplastic expansion of the zG evoked by βcat-GOF results not from an increase in proliferation but rather from a block in zonal transdifferentiation that is exacerbated when combined with a proliferative stimulus. βcat-GOF adrenals also showed enhanced expression of *Pde2a* (*Phosphodiesterase 2A*), an inhibitor of the cAMP/PKA signaling pathway within the zF, suggesting that βcat-GOF may maintain zG identify in part through the suppression of zF identity. Together, our data identify a proliferation-independent mechanism, a block in zonal transdifferentiation, whereby βcat-GOF can cause tissue hyperplasia.

RESULTS {#S2}
=======

Stabilization of β-Catenin in zG Cells Results in Expansion of the zG {#S3}
---------------------------------------------------------------------

To investigate the cellular mechanisms by which activation of canonical Wnt/β-catenin signaling leads to adrenal hyperplasia, we generated *AS*^*Cre/+*^ :: *Ctnnb1*^flox(ex3)/+^ (βcat-GOF) mice by crossing mice harboring the zG-specific Aldosterone Synthase-Cre (*AS*^*Cre/+*^) allele ([@R18]) with mice harboring LoxP sites flanking the third exon of β-catenin (*Ctnnb1*^*flox(ex3)/+*^) ([@R21]) mice ([Figure 1A](#F1){ref-type="fig"}). Deletion of the third exon of β-catenin results in an in-frame protein devoid of GSK3β-specific phosphorylation sites that normally target β-catenin for degradation. Thus, in these mice β-catenin is stabilized specifically within zG cells and the β-catenin pathway is constitutively activated. For controls, we employed *AS*^*Cre/+*^:: *Ctnnb1*^+/+^ mice (βcat-WT). Increased expression of *Axin2* and *Lef1*, well-established β-catenin downstream targets, confirmed activation of this pathway in βcat-GOF adrenals ([Figure 1B](#F1){ref-type="fig"}).

To begin to understand the impact of βcat-GOF on adrenal homeostasis over time, we analyzed the β-catenin expression domain in mice at different ages. β-catenin expression in βcat-WT adrenals was largely restricted to the zG at all ages ([Figure 1C](#F1){ref-type="fig"}), consistent with a previous report ([@R5]). In contrast, βcat-GOF adrenals showed a progressive expansion of the region expressing β-catenin (β-catenin^+^) into the underlying zF region ([Figure 1C](#F1){ref-type="fig"}; [Figure S1A](#SD1){ref-type="supplementary-material"}). Both sexes displayed a similar pattern in adult and aged mice ([Figures S1B](#SD1){ref-type="supplementary-material"} and [S1C](#SD1){ref-type="supplementary-material"}). Given that both male and female mice exhibited similar characteristics, unless otherwise noted, studies were performed with female mice.

To confirm that the expanded region arises from stabilized β-catenin^+^ cells, βcat-WT and βcat-GOF adrenals were co-stained with two β-catenin antibodies: one that recognizes total β-catenin and one that is specific to exon 3, the exon that is excised following recombination. In βcat-WT adrenals, we observed co-staining of cells underneath the capsule, corresponding to the morphological zG. Conversely, staining for β-catenin containing exon 3 was nearly completely absent from the expanded zG in βcat-GOF adrenals ([Figure S1D](#SD1){ref-type="supplementary-material"}). This result confirms that nearly all zG cells in the expanded region underwent recombination of the *Ctnnb1* locus. Additionally, to confirm active Wnt signaling within the expanded region, we co-stained for β-catenin and Lef1, which revealed that most β-catenin positive cells co-expressed Lef1 ([Figure S1E](#SD1){ref-type="supplementary-material"}). For these and all subsequent studies, unless otherwise stated, the antibody that recognizes total β-catenin was used.

To confirm the cellular identity of β-catenin-expressing cells within the expanded region, we performed co-immunostaining for β-catenin and Dab2, an established zG marker ([@R41]). Similar to βcat-WT adrenals, Dab2 expression co-localized with β-catenin in βcat-GOF adrenals ([Figure 1D](#F1){ref-type="fig"}), indicating that cells within the expanded region maintained a zG-like identity. To further validate the zG identity of cells within the expanded β-catenin^+^ region, we performed immunostaining for Gαq, the alpha subunit of the heterotrimeric G protein activated by Angiotensin II (AngII) in zG cells ([@R10]). Analysis of βcat-WT adrenals showed that Gαq co-localizes with both β-catenin and Dab2 ([Figure S1F](#SD1){ref-type="supplementary-material"}). Consistent with their expression of Dab2, β-catenin^+^ cells in βcat-GOF adrenals also co-stained for Gαq ([Figure 1E](#F1){ref-type="fig"}; [Figure S1G](#SD1){ref-type="supplementary-material"}). To rule out that these cells also exhibit zF-like features, we examined the expression pattern of aldo-keto reductase family 1 member B7 (Akr1b7), an established zF marker ([@R1]), which revealed mutually exclusive expression of β-catenin and Akr1b7 in both βcat-WT and βcat-GOF adrenals ([Figure 1F](#F1){ref-type="fig"}).

To determine whether the expansion of the zG region resulted from hypertrophy or hyperplasia, we performed histomorphometric analysis of βcat-WT and βcat-GOF adrenals to assess changes in cell density. Analysis of the number of DAPI-positive nuclei per unit area (mm^2^) within each region revealed that the cellular density within the expanded zG region of βcat-GOF adrenals was indistinguishable from that within the zG region of βcat-WT adrenals (14,002 ± 796 versus 13,704 ± 780 nuclei/mm^2^, respectively) and markedly different from the zF (6,838 ± 502 versus 7,212 ± 990 nuclei/mm^2^, respectively) ([Figure 1G](#F1){ref-type="fig"}), indicating that the expansion in the zG area in βcat-GOF mice is the result of hyperplasia and not hypertrophy. Consistent with a progressive hyperplastic increase in total mass of the zG-layer, overall adrenal weight was increased in aged βcat-GOF mice, compared with βcat-WT controls ([Figure S1H](#SD1){ref-type="supplementary-material"}). Together, these data show that stabilization of β-catenin within zG cells leads to a progressive hyperplastic expansion of the zG.

Stabilization of β-Catenin in zG Cells Blocks zG-to-zF Cell Transdifferentiation {#S4}
--------------------------------------------------------------------------------

To understand the cellular mechanisms underlying zG expansion in βcat-GOF mice, we first tested whether the hyperplastic expansion resulted from increased proliferation, a known response of elevated Wnt signaling ([@R36]). To address this, the proliferation index of zG cells in βcat-WT and βcat-GOF adrenals was determined by scoring the number of Ki67-positive cells per zG area. For these studies, β-catenin expression was used to define the zG. Although a modest increase in Ki67-positive cells was observed in the zG of βcat-GOF compared with control adrenals in both adult and aged mice ([Figure S2A](#SD1){ref-type="supplementary-material"}), when normalized by the zG area the fraction of proliferating cells was significantly decreased ([Figure 2A](#F2){ref-type="fig"}). This result indicates that the expansion of β-catenin-expressing cells in βcat-GOF mice was likely not due to increased cell division. Since enhanced cell survival (i.e., reduced apoptosis) could also contribute to the expansion, we next assessed the impact of βcat-GOF on apoptosis by staining for activated caspase-3 or TUNEL in βcat-WT and βcat-GOF adrenals. No differences were observed between groups ([Figures S2B](#SD1){ref-type="supplementary-material"}--[S2E](#SD1){ref-type="supplementary-material"}), despite an overall low level of apoptosis. Thus, these results indicate that the zG expansion in βcat-GOF mice does not arise via changes in cell proliferation or cell death.

We next examined whether the expanded zG region in βcat-GOF adrenals resulted from a block in zonal transdifferentiation ([@R18]). To address this, we performed functional lineage-tracing analysis using mTmG reporter mice ([@R34]) ([Figure 2B](#F2){ref-type="fig"}). Consistent with our prior findings ([@R18]), GFP marked both zG cells (as defined by either Dab2 or Gαq co-expression) and zF cells (defined by either Akr1b7 co-expression or the absence of Dab2 or Gαq expression) in βcat-WT adrenals ([Figures 2C](#F2){ref-type="fig"}--[2E](#F2){ref-type="fig"}). In contrast, GFP expression in βcat-GOF adrenals was confined to zG cells, with nearly all zF cells negative for GFP expression ([Figures 2](#F2){ref-type="fig"}C--[2E](#F2){ref-type="fig"}) indicating a block in transdifferentiation. The few GFP-positive cells in the zF region failed to express β-catenin, establishing that these cells had escaped recombination of the *Ctnnb1*^flox(ex3)^ allele ([Figure 2F](#F2){ref-type="fig"}, arrowheads). Together, these data indicate that stabilization of β-catenin within zG cells leads to progressive zG hyperplasia, in part, through a block in zonal transdifferentiation, defining a new paradigm for hyperplastic expansion.

βcat-GOF Leads to Induction of Pde2a, a Negative Regulator of the zF {#S5}
--------------------------------------------------------------------

Recently, phosphodiesterases were identified as potential negative regulators of zF identity. By hydrolyzing and inactivating cAMP, an essential signaling intermediate of the PKA signaling pathway, zF function is blocked ([@R31]) ([Figure 3A](#F3){ref-type="fig"}). Phosphodiesterase activity within the adrenal gland is almost exclusively the result of PDE2A in the zG ([@R30]; [@R48]). To assess the impact of βcat-GOF on phosphodiesterase activity, we first performed quantitative real-time PCR for *Pde2a*, which revealed a significant upregulation in βcat-GOF adrenals compared with controls ([Figure 3B](#F3){ref-type="fig"}). In addition, immunohistochemical analysis detected Pde2a in the zG domain in control mice as well as the expanded zG domain in βcat-GOF adrenals overlapping with β-catenin expression ([Figure 3D](#F3){ref-type="fig"}). We next performed immunostaining to assess the global phosphorylation status of downstream cAMP/PKA-substrates, which confirmed inhibition of cAMP/PKA signaling in the β-catenin-positive zG regions ([Figure 3E](#F3){ref-type="fig"}).

To assess whether *Pde2a* is a direct target of canonical Wnt signaling, we searched for putative TCF/LEF consensus sequences (5′-A/T A/T CAAAG-3′) within the promoter and first intron of the *Pde2a* gene locus. Chromatin immunoprecipitation (ChIP) analysis using anti-β-catenin antibody combined with whole adrenal extracts revealed two active TCF/LEF binding sites, located at positions +19,762 (first intron) and −8,545 (distal promoter) with respect to the transcriptional start site ([Figure 3C](#F3){ref-type="fig"}). These two sequences were named Pde-A and Pde-B, respectively. A third putative TCF/LEF binding site, located at position +873 and named Pde-X, did not reveal β-catenin binding ([Figure 3C](#F3){ref-type="fig"}). Altogether, these data suggest that βcat-GOF maintains a zG identity and blocks transdifferentiation, at least in part, through inhibition of zF identity by directly stimulating the expression of *Pde2a*, a key negative regulator of zF-dependent cAMP/PKA-mediated signaling.

Stabilization of β-Catenin in zG Cells Results in Mild Aldosteronism {#S6}
--------------------------------------------------------------------

Previous studies in mice and humans show a positive correlation between activation of Wnt signaling in the adrenal and increased steroidogenesis ([@R7]; [@R49]; [@R54]; [@R55]). To determine whether stabilization of β-catenin within zG cells results in enhanced production of aldosterone, we quantified the plasma levels of aldosterone and plasma renin activity (PRA) in aged animals. βcat-GOF mice show an \~3.5-fold increase in the levels of aldosterone compared to βcat-WT mice (445 ± 317 pg/mL versus 131 ± 83 pg/mL, respectively) ([Figure S3A](#SD1){ref-type="supplementary-material"}). Despite this, analysis of PRA showed no difference between βcat-GOF and βcat-WT mice (1,024 ± 472 ng/mL/h versus 716 ± 441 ng/mL/h, respectively) ([Figure S3B](#SD1){ref-type="supplementary-material"}). Thus, the increase in aldosterone production in βcat-GOF mice is insufficient to suppress the renin-AngII-aldosterone system (RAAS) and indicates that the relative decrease in zG-specific proliferation is not a consequence of altered RAAS activity.

Trophic Factor Stimulation Exacerbates the Block in Transdifferentiation {#S7}
------------------------------------------------------------------------

Feedback loops and tissue-specific trophic factors tightly regulate endocrine tissue mass. For example, chronic activation of RAAS has been associated with an increase in zG proliferation ([@R32]; [@R35]). To assess the impact of trophic factor induction on the βcat-GOF-induced block in transdifferentiation, we utilized *AS*^*Cre/Cre*^ mice (AS(KO)), a model of CYP11B2(AS) deficiency that results in a dramatic \~5-fold increase in RAAS activity from an early age ([@R18]). By combining this model with the βcat-GOF model, we generated *AS*^*Cre/Cre*^ :: *Ctnnb1*^flox(ex3)^ (AS(KO)-βcat-GOF) mice ([Figures 4A](#F4){ref-type="fig"} and [4B](#F4){ref-type="fig"}). Activation of RAAS using AS(KO) mice led to an \~2-fold increase in the zG proliferative index in both βcat-WT and βcat-GOF mice, which was completely blocked by candesartan (an AngII receptor antagonist) ([Figures 4C](#F4){ref-type="fig"} and [4D](#F4){ref-type="fig"}). Next, we assessed the impact of enhanced trophic drive on zG area. Analysis of the zG (as defined by Gαq expression) revealed a notable expansion in AS(KO) mice compared with AS(Cre) controls (54% ± 11% of cortex in AS(KO) versus 16% ± 2% in AS(Cre)) ([Figures 4E](#F4){ref-type="fig"} and [4F](#F4){ref-type="fig"}). However, when combined with β-catenin stabilization (AS(KO)-βcat-GOF) the zG occupied nearly the entire cortex (98% ± 4%) ([Figures 4E](#F4){ref-type="fig"} and [4F](#F4){ref-type="fig"}). Remarkably, while a partial block in zG expansion was observed in AS(KO) controls (24% ± 7%) following treatment with candesartan, it had no impact on zG area in AS(KO)-βcat-GOF mice (98% ± 1% of cortex) ([Figures 4E](#F4){ref-type="fig"} and [4F](#F4){ref-type="fig"}). Moreover, gross analysis of adrenals from AS(KO)-βcat-GOF mice revealed a marked increase in weight (10.1 ± 5.5 mg) compared with adrenals from AS(KO), βcat-GOF, or βcat-WT mice (combined mean of 3.1 ± 0.8 mg), which was blocked by treatment with candesartan, AS(KO)-βcat-GOF (4.3 ± 2.2 mg) versus AS(KO) controls (2.6 ± 0.5 mg) ([Figure 4G](#F4){ref-type="fig"}). Taken together, these results indicate that enhanced trophic drive via AngII induces zG expansion via cell proliferation, whereas βcat-GOF induces zG expansion via a block in transdifferentiation and that the combination of both leads to a dramatic increase in adrenal mass.

DISCUSSION {#S8}
==========

Wnt proteins are well-established growth stimulatory factors that drive cellular proliferation in a broad range of tissues ([@R36]). Aberrant activation of the Wnt/β-catenin signaling pathway has also been implicated in the initiation and progression of numerous cancers, including adenocarcinoma of the colon and of the adrenal cortex ([@R36]; [@R38]; [@R57]). Given the diverse homeostatic mechanisms that regulate these tissues and their divergent rates of tissue turnover, it is possible that activation of Wnt/β-catenin signaling may have multiple distinct downstream effects. In the intestine, a rapidly cycling tissue, stabilization of oncogenic β-catenin or deletion of key tumor-suppressor genes results in a prompt increase in proliferation leading to tissue hyperplasia ([@R4]; [@R27]; [@R40]; [@R42]). In contrast, how activation of Wnt/β-catenin signaling drives hyperplasia in the adrenal cortex, a slowly cycling tissue, is not well understood. Our data show that βcat-GOF mice develop zG hyperplasia via a block in zonal transdifferentiation rather than an increase in cell proliferation ([Figure 4H](#F4){ref-type="fig"}). In addition, we found no change in PRA between βcat-GOF and βcat-WT mice indicating that suppression of RAAS activity does not play a significant role in modulating the zG response to βcat-GOF. In contrast, activation of RAAS leads to exacerbation of the block in transdifferentiation and can lead to frank adrenomegaly, an observation with potential clinical consequence. Altogether, our data raise the intriguing possibility that activation of Wnt/β-catenin signaling may contribute to hyperplastic expansion in a range of tissues through effects on cellular differentiation/cell-fate commitment, independent of proliferation, especially in neoplasms arising in slowly cycling tissues (e.g., adrenocortical carcinoma, medulloblastoma, craniopharyngioma, and thyroid carcinoma) ([@R13]; [@R43]; [@R46]).

Several recent studies have assessed proliferation in the adrenal cortex following activation of Wnt/β-catenin signaling. Sporadic activation of βcat-GOF within the adrenal cortex, using an Akr1b7 minimal promoter Cre driver that targets a subset of both zG and zF cells, leads to ectopic zG expansion in 5-month-old mice without an increase in proliferation ([@R6], [@R7]). More recent analysis of ZNRF3 LOF within the adrenal cortex, using a steroidogenic factor 1 (Sf1-Cre) driver that targets all zG and zF cells, revealed adrenal hyperplasia and a corresponding increase in zF proliferation ([@R5]). In contrast, the zG cells in the Sf1-Cre model did not show an increase in proliferation ([@R5]), consistent with the overall decrease in proliferation in our model following βcat-GOF. Also, in contrast to our βcat-GOF model, activation of Wnt/β-catenin signaling in zG cells, following ZNRF3 LOF, was not sufficient to block transdifferentiation of zG to zF cells ([@R5]), consistent with a reduced dose effect of ZNRF3 LOF on canonical Wnt/β-catenin compared with our βcat-GOF model.

Adrenal physiology and the incidence of adrenal disease are influenced by sex differences, in both humans and mice ([@R11]; [@R17]). Female mice have larger adrenals and show higher circulating levels of aldosterone and corticosterone compared with males ([@R8]; [@R47]). A recent study designed to elucidate cellular and molecular mechanisms underlying these sexually dimorphic traits led to the discovery that female mice utilize a progenitor/stem cell compartment located in the capsule, which is actively suppressed by male hormones ([@R20]). In contrast, adrenocortical homeostasis in male mice relies on proliferation within steroidogenic cells themselves ([@R20]). In addition, male hormones have been shown to increase canonical WNT signaling within the adrenal, which serves to antagonize PKA signaling leading to slower adrenocortical turnover ([@R16]). To investigate the impact of sex on the βcat-GOF-induced block in transdifferentiation, we studied male and female mice at both adult and aged time points. The results of this analysis revealed no differences in the pattern of zG cell accumulation between male and female βcat-GOF mice, indicating that sex is not an important determinant of this trait.

Recently, the maintenance of two adjacent, functionally distinct, zones such as the zG and the zF, has been ascribed to the reciprocal inhibitory effects of the cAMP/PKA and the Wnt/β-catenin pathways, in the zF and the zG, respectively ([@R14]; [@R31]; [@R53]). Phosphodiesterases have emerged as potential inhibitors of zF identity, as their expression is physiologically suppressed in the zF by the epigenetic regulator EZH2 ([@R31]). zG-specific expression of PDE2A is highly conserved among several species, including mice and humans ([@R48]), suggesting that PDE2A exerts a conserved function in the zG. Despite this, little is known regarding its role in adrenal zonation. Our data indicate that PDE2A is a direct target of Wnt/β-catenin signaling and may function, at least in part, as an inhibitor of zF identity by suppressing cAMP/PKA signaling. This hypothesis is consistent with a previous study indicating that PDE2A is over-expressed preferentially in adrenal tumors carrying activating mutations in the gene encoding β-catenin ([@R15]). Altogether, our results encourage further studies on the potential role of phosphodiesterases in regulating zonation and potentially transdifferentiation within the adrenal cortex.

We previously showed that an ongoing process of zG-to-zF zonal transdifferentiation during postnatal development is the main source of zF cells ([@R18]), though the mechanisms that regulate this process remain poorly understood ([@R37]). Under conditions where transdifferentiation is absent, the zF can be maintained by alternative cellular pathways ([@R18]). Whether similar alternative pathways are responsible for zF maintenance in the βcat-GOF mice remains to be determined. An alternative cellular pathway for maintenance of the zF might involve recruitment of subcapsular and/or capsular progenitor cells, which bypass the zG state. Another possibility might involve replication of zF cells formed during fetal development, prior to the development of the zG during early post-natal life. Testing such models will be important avenues for future research.

Chronic activation of RAAS has been implicated in cardiovascular end-organ damage independent of its role in regulation of intravascular volume and blood pressure ([@R12]; [@R33]). Like other endocrine tissues, the zG is regulated by a feedback loop that involves AngII, an essential trophic factor that controls zG cell proliferation ([@R32]; [@R35]). Consistent with this, we found that chronic activation of RAAS in the setting of aldosterone synthase deficiency leads to an increase in cellular proliferation in both βcat-GOF mice and βcat-WT mice. These findings suggest that RAAS activation, and specifically AngII, may contribute to GOF events with potentially important clinical implications in the context of somatic and/or germline mutations that lead to βcat-GOF within the zG. Delineation of the impact of chronic RAAS activation will require careful retrospective analysis in patients discovered to have underlying βcat-GOF mutations at the time of resection or prospective analysis in cohorts with germline mutations.

In conclusion, our work provides new mechanistic insight into the control of adrenocortical zonation, by demonstrating that the Wnt/β-catenin pathway drives zG hyperplasia by blocking zonal transdifferentiation, potentially through augmentation of negative regulators of the cAMP/PKA signaling pathway and zF identity. Further, our finding that RAAS activation is an important enhancer of βcat-GOF-induced hyperplastic zG expansion may have important clinical implications for the treatment of patients with somatic or germline mutations leading to activation of Wnt/β-catenin signaling within the adrenal cortex.

STAR★METHODS {#S9}
============

LEAD CONTACT AND MATERIALS AVAILABILITY {#S10}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, David T. Breault (<david.breault@childrens.harvard.edu>). This study did not generate new unique reagents.

EXPERIMENTAL MODEL AND SUBJECT DETAILS {#S11}
--------------------------------------

All animal procedures were approved by the Boston Children's Hospital Institutional Animal Care and Use Committee. Generation of the aldosterone synthase (AS)-Cre strain (Cyp11b2^tm1.1(cre)Brlt^) was previously described ([@R18]). To generate bigenic *Cyp11b2*^tm1.1(cre)Brlt/+^:: *Ctnnb1*^tm1Mmt^ mice (referred to as βcat-GOF or bGOF), the *Cyp11b2*^tm1.1(cre)Brlt^ strain was crossed with the *Ctnnb1*^tm1Mmt^ strain ([@R21]). To generate trigenic *Cyp11b2*^tm1.1(cre)Brlt/+^:: *Ctnnb1*^tm1Mmt^:: *Gt(ROSA)26Sor*^tm4(ACTΒ-tdTomato,-EGFP)Luo/J^ mice (referred to as βcat-GOF::mTmG), the βcat-GOF mice were crossed with the *Gt(ROSA)26Sor*^tm4(ACTΒ-tdTomato,-EGFP)Luo/J^ (mTmG) Cre-reporter line ([@R34]). AS deficiency was achieved by breeding the AS-Cre allele to homozygosity (AS(KO) mice), as previously described ([@R18]). AS(KO)-βcat-GOF mice were bred by intercrossing AS(KO) mice with *Ctnnb1*^tm1Mmt^ mice. All mice were maintained on a mixed sv129-C57BL/6 genetic background, with free access to food and water, under a 12-hour light/12-hour dark cycle. Mice were housed in a specific-pathogen-free grade facility, in an OptiMICE cage system, in groups of 2 to 5 animals per cage. All mice used for the experiments were drug and test naive. Female mice were used unless otherwise stated. To control for genetic background, whenever possible, experiments were performed using littermate control mice (βcat-WT or bWT) that did not carry the *Ctnnb1*^tm1Mmt^ allele and were positive for the *Cyp11b2*^tm1.1(cre)Brlt^ and the *Gt(ROSA)26Sor*^tm4(ACTΒ-tdTomato,-EGFP)Luo/J^ allele. Throughout the main text, mice heterozygous for the AS-Cre allele are referred to as *AS*^*Cre/+*^, and mice heterozygous for the *Ctnnb1*^tm1Mmt^ allele are referred to as *Ctnnb1*^*flox(ex3)/+*^. Studies were conducted on age-matched cohorts of mice that were 'young adult' (10 weeks of age), 'adult' (15-to-21 weeks of age) or 'aged' (38-to-53 weeks of age).

METHOD DETAILS {#S12}
--------------

### Gene Expression Analysis {#S13}

RNA was purified from whole adrenals cleaned of adherent fat and homogenized in TRI® Reagent (Sigma) using the Direct-zol™ RNA kit (Zymo Research), following the manufacturer's protocol. Further processing of total RNA involved reverse transcription into cDNA using the High-Capacity cDNA Reverse Transcription Kit (Life Technologies). Gene expression analysis was performed by Real Time quantitative PCR (RTqPCR) using the QuantStudio 6 Flex thermocycler (Life Technologies). Technical duplicates were used to control for technical variability. The TaqMan Universal PCR Master Mix and the following Taqman primers from Life Technologies were used: *Axin2* (Mm00443610_m1), *Lef1* (Mm00550265_m1), *Cyp11b2* (Mm01204955_g1), *Pde2a* (Mm01136644_m1) and *Actb* (Mm026119580_g1). *Actb* transcripts, encoding β-actin, were used as the internal control and data were expressed using the 2^−ddCt^ method. Sample size was estimated based on the published literature and our experience and is indicated in the figure legends.

### Tissue preparation, immunofluorescence, microscopy and quantification {#S14}

Mouse adrenals were cleared of adherent fat, weighed, fixed in 4% paraformaldehyde for 1 to 3 hours at 4°C, dehydrated in ethanol, xylene and embedded in paraffin blocks. Five μm-thick sections were processed for immunostaining by stepwise rehydration and permeabilization with 50 mM Tween-20 in PBS. Antigen retrieval was performed in 10 mM Sodium Citrate pH 6.0. Blocking was performed with 0.3% Tween-20 (Merck Millipore), 0.5% bovine serum albumin (BSA, Sigma), 10% normal goat serum (Sigma) in PBS, for 1h at room temperature. 0.5% sodium dodecyl sulfate (SDS, Fisher BioReagents) was also added to the blocking solution specifically when the primary anti-AS antibody was used (see below for antibody details). Immunostaining was done using the following primary antibodies: anti-β-catenin (mouse monoclonal, BD Biosciences, 610153; and rabbit polyclonal, Abcam, ab16051), anti-GFP (chicken polyclonal, Aves Labs, GFP-1020), anti-activated Caspase 3 (rabbit monoclonal, BD Biosciences, 559565), anti-Dab2 (mouse monoclonal, BD Biosciences, 610464), anti-Akr1b7 (rabbit polyclonal, kindly provided by Dr. Pierre Val and Dr. Antoine Martinez ([@R1]; [@R6])), anti-Gαq (rabbit polyclonal, Abcam, ab75825), anti-AS (rabbit polyclonal, kindly provided by Dr. Celso E. Gomez-Sanchez ([@R18])), anti-Ki67 (rabbit monoclonal, Lab Vision, RM-9106), anti-Lef1 (rabbit monoclonal, Abcam, ab137872), anti-Phospho-(Ser/Thr) PKA Substrate Antibody (rabbit polyclonal, Cell Signaling Technology, 9621), anti-β-catenin(ex3) (rabbit monoclonal, Abcam, ab32572), anti-PDE2A (rabbit polyclonal, Proteintech, 55306--1-AP). TUNEL staining was performed using the Click-iT™ Plus TUNEL Assay (Invitrogen), according to manufacturer's instructions. All primary antibodies were used at a 1:200 dilution and secondary antibodies at a 1:500 dilution. We used the following secondary antibodies for indirect staining: donkey anti-rabbit conjugated with Alexa Fluor 647, goat anti-mouse Alexa Fluor 594 and goat anti-chicken Alexa Fluor 488 (Molecular Probes). Sections were counter-stained with DAPI (4′,6-diamidino-2-phenylindole) and mounted in Prolong Gold Mount Solution (Thermo Fisher Scientific). Images were captured with a Nikon upright Eclipse 90i microscope. For every image, three Z stacks were collected and deconvoluted to obtain the best resolution using the LIS-Elements Nikon software. Background autofluorescence was acquired from an empty green or red channel to allow subsequent subtraction of autofluorescence (e.g., from red blood cells and lipofuscin) from the other channels using the Image Calculator tool in Fiji software ([@R44]) (open source). Quantification of AS-, Ki67-, TUNEL- and activated Caspase 3-positive cells or Gαq and β-catenin-positive areas was performed using one complete equatorial section per mouse adrenal. Absolute cell numbers were normalized by zone-specific area (mm^2^), as indicated. Quantification of nuclear density was performed on representative regions of interest from equatorial sections by counting DAPI-positive nuclei per zone-specific area (mm^2^). Multiple measurements were taken from different regions of zG on βcat-GOF sections, to better address the complexity of the tissue. At least three replicates were performed for each experiment. Each replicate was generated from tissue from different mice.

### Hormone Analysis {#S15}

Plasma was collected in a stress-free environment by rapid non-terminal retro-orbital blood draw using thin hematocrit capillaries (Fisher Scientific). Aldosterone levels were determined on heparinized plasma (pre-diluted 2.5 times in PBS + 0.1% BSA) using an aldosterone I125 radioimmunoassay according to the manufacturer's instructions (Tecan). Plasma renin activity was determined on EDTA-collected plasma using a competitive radioimmunoassay for Angiotensin I following the manufacturer's instructions (Tecan). To rule out the impact of limiting amounts of angiotensinogen substrate in the plasma, an excess (about 180 ng) of angiotensinogen 1--14 renin substrate porcine (Sigma) was added to every sample, calibrator and control before quantification.

### Chromatin immunoprecipitation (ChIP) assay {#S16}

ChIP was performed using the High-Sensitivity ChIP Kit (Abcam, ab185913) following the manufacturer's instructions with minor modifications. Adrenals from C57BL/6J mice were collected, cleaned of adherent fat, weighed, snap frozen in liquid nitrogen and stored at --80 °C. Twelve adrenals (20 mg of tissue) were combined and briefly homogenized with a bench-top TissueLyser II (QIAGEN), followed by crosslinking using 1% formaldehyde for 15 min at room temperature. This reaction was quenched with 1.25 M glycine. Samples were washed with ice cold PBS and homogenized in Lysis Buffer containing Protease Inhibitor Cocktail (from the High-Sensitivity ChIP Kit). After washing, chromatin was sheared into 100--300 bp fragments using a Probe Sonicator (Misonix Inc.) and the concentration of chromatin DNA was determined using NanoDrop (Thermo Fisher Scientific). To perform the immunoprecipitation (IP) assay 0.8 µg of antibody was combined with 2 µg of chromatin DNA, using each of the following antibodies: anti-β-catenin (Cell Signaling, 9581s), anti-Histone H3 (Abcam, ab1791) as positive control, and Non-Immune IgG (from the High-Sensitivity ChIP Kit) as negative control. Immuno-complexes and small aliquots of lysate (for input controls) were subjected to reverse crosslinking, release and purification of DNA using DNA Release Buffer and RNase A (from the High-Sensitivity ChIP Kit). Quantification of DNA levels was performed by RTqPCR analysis using Power SYBR® Green PCR Master Mix (4367659, Thermo Fisher Scientific) in a QuantStudio 6 Flex thermocycler (Life Technologies). Primers are listed in [Table S1](#SD1){ref-type="supplementary-material"}.

QUANTIFICATION AND STATISTICAL ANALYSIS {#S17}
---------------------------------------

Two-tailed Student's *t*-Test was used for comparisons between groups of two. For every comparison, the F-test was used to assess whether two groups had different variances. If this was the case, the two-tailed Welch t test was used instead of the Student's *t*-Test. One-Way or Two-Way ANOVA and Tukey post hoc analysis (multiple comparison test) were used for comparisons between groups of three or more, unless otherwise specified. Prism 7 software (GraphPad) was used for statistical analysis. No power analysis was performed, size estimation was based on published literature and on our experience. All data were included, no exclusion method was applied. The statistical details of the experiments can be found in the figure legends, whereby 'n' values correspond to the number of independent mice. Data are presented as Mean ± Standard Error of the Mean (SEM).

DATA AND CODE AVAILABILITY {#S18}
--------------------------

This study did not generate/analyze datasets/code.
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![Stabilization of β-Catenin in zG Cells Results in Expansion of the zG\
(A) Schematic representation of the alleles comprising βcat-GOF (bGOF) mice. Cre recombinase is expressed under the control of the aldosterone synthase (AS) promoter and drives excision of the third LoxP-flanked exon of *Ctnnb1*, encoding β-catenin, leading to stabilization in AS-expressing zG cells. βcat-WT (bWT) control mice have two copies of the wild-type *Ctnnb1* allele.\
(B) Quantitative real-time PCR for *Axin2* (n = 7 βcat-WT and 5 βcat-GOF mice) and *Lef1* (n = 7 βcat-WT and 6 βcat-GOF mice).\
(C) Representative adrenal sections stained for β-catenin (β-cat, red) (n = 5 βcat-WT and 10 βcat-GOF mice).\
(D) Representative adrenal sections co-stained for β-catenin (β-cat, red) and Dab2 (green) (n = 3 βcat-WT and 4 βcat-GOF mice).\
(E) Representative adrenal sections co-stained for β-catenin (β-cat, red) and Gαq (green) (n = 7 βcat-WT and 9 βcat-GOF mice).\
(F) Representative adrenal sections co-stained for β-catenin (β-cat, red) and Akr1b7 (green) (n = 3 mice for each genotype).\
(G) Analysis of cellular density using quantification of DAPI-stained nuclei normalized per unit area (dots represent single measurements; *n* from left to right = 6, 10, 4, 4). All sections were counterstained with nuclear DAPI (blue) and were from adult mice unless otherwise stated. The dotted lines define the border between β-catenin-positive and -negative regions. c, capsule.\
zG, zona Glomerulosa. zF, zona Fasciculata. Scale bars: 50 μm. *ns*, not significant. \*p \< 0.05; \*\*\*\*p \< 0.0001. Data are represented as mean ± SEM.\
See also [Figure S1](#SD1){ref-type="supplementary-material"}.](nihms-1586763-f0002){#F1}

![Stabilization of β-Catenin in zG Cells Blocks zG-to-zF cell Transdifferentiation\
(A) Left: representative adrenal sections co-stained for β-catenin (β-cat, red) and Ki67 (green). Right: quantification of the Ki67-positive cells normalized for the β-catenin-positive zG domain (zG proliferation index) (from left to right, top to bottom, n = 5, 5, 9, 7, 6, 8 mice).\
(B) Schematic representation of the alleles comprising βcat-GOF::mTmG mice. βcat-WT::mTmG control mice have two copies of the wild-type *Ctnnb1* allele.\
(C) Representative adrenal sections co-stained for Dab2 (red) and GFP (green) (n = 9 mice for each genotype).\
(D) Representative adrenal sections co-stained for Gαq (red) and GFP (green) (n = 9 mice for each genotype).\
(E) Representative adrenal sections co-stained Akr1b7 (red) and GFP (green) (n = 3 mice for each genotype).\
(F) Representative adrenal sections co-stained for β-catenin (β-cat, red) and GFP (green) (n = 5 mice for each genotype). All sections were counterstained with nuclear DAPI (blue) and were from adult mice. Arrowheads point at GFP-positive and β-catenin-negative zF cells. All dotted lines define the border between positive and negative regions for β-catenin, Dab2, Gαq, or Akr1b7, as indicated.\
c, capsule. zG, zona Glomerulosa. zF, zona Fasciculata. Scale bars: 50 μm. *ns*, not significant; \*\*\*p \< 0.001. Data are represented as mean ± SEM.\
See also [Figure S2](#SD1){ref-type="supplementary-material"}.](nihms-1586763-f0003){#F2}

![Stabilization of β-Catenin in zG Cells Results in Upregulation of Pde2a\
(A) Schematic representation of the effects of the cAMP/PKA signaling pathway on zG and zF. Pde2a catalyzes the hydrolysis of cAMP to AMP.\
(B) Quantitative real-time PCR for *Pde2a* (n = 5 mice for each genotype).\
(C) Chromatin immunoprecipitation of three consensus TCF/LEF sequences within the *Pde2a* gene, named Pde-A, Pde-B and Pde-X, located at +19,762 bp (within the first intron), --8,545 bp (within the distal promoter), and +873 bp (within the first intron) with respect to the transcriptional start site (arrow). The well-characterized consensus TCF/LEF site within *Axin2*, located at +1,926 bp, was used as positive control ([@R24]). Fold change relative to IgG. Statistical analysis was performed using Welch's t test (n = 4--5).\
(D) Representative adrenal sections co-stained for β-catenin (β-cat, red) and Pde2a (green) (n = 3 mice for each genotype).\
(E) Representative adrenal sections co-stained for β-catenin (β-cat, red) and phosphorylated substrates of PKA (PKA\_(p)sub, green), (n = 3 mice for each genotype). All sections were counterstained with nuclear DAPI (blue) and were from adult mice. The dotted lines define the border between positive and negative regions for β-catenin. c, capsule.\
zG, zona Glomerulosa; zF, zona Fasciculata; p, phosphorylation; Ex, exon(s). Scale bars: 50 μm. *ns*, not significant; \*p \< 0.05, \*\*p \< 0.01. Data are represented as mean ± SEM.](nihms-1586763-f0004){#F3}

![Activation of RAAS Leads to Marked Adrenal Hyperplasia\
(A) Schematic representation of the alleles comprising AS(KO) and AS(KO)-βcat-GOF mice. The presence of two AS-Cre alleles results in RAAS activation.\
(B) Left: schematic representation of RAAS under physiological conditions. Center: activation of RAAS in AS(KO) mice. Right: RAAS activity is blocked by the AngII receptor antagonist Candesartan.\
(C) Representative adrenal sections co-stained for β-catenin (β-cat, red) and Ki67 (green). Arrowheads mark co-positive cells.\
(D) Quantification of the Ki67-positive cells from (C) normalized for the β-catenin-positive domain (zG proliferation index).\
(E) Representative adrenal sections stained for Gαq (green).\
(F) Quantification of Gαq-positive area from (E) normalized for cortical area.\
(C and D) From left to right and top to bottom: n = 5, 5, 6, 5, 6, and 5 mice.\
(E and F) From left to right: n = 5, 5, 6, 5, 6, and 5 mice.\
(G) Weight of adrenal glands from adult mice (from left to right, n = 8, 6, 5, 7, 8, and 4 mice).\
(H) Schematic representation of the effect of RAAS activation on β-catenin mice. Light blue circles represent zG cells. Red circles represent zF cells. Blue nuclei indicate proliferating cells. Arrows (→) indicate the ongoing process of zG-to-zF cell transdifferentiation, which allows zG cells to migrate into the zF. Transdifferentiation is blocked in βcat-GOF adrenals, as indicated by the symbol (⟂). zG proliferation index (total number of Ki67-positive cells normalized by zG area) is decreased or unaltered in zG of βcat-GOF compared to controls and increased in βcat-GOF exposed to activated RAAS. All stained sections were counterstained with nuclear DAPI (blue) and were obtained from young adult mice. The dotted lines define the border between β-catenin/Gαq-positive and -negative regions.\
zG, zona Glomerulosa; zF, zona Fasciculata; MR, mineralocorticoid receptors; Aldo, aldosterone; AngII, Angiotensin II; cande, Candesartan. Scale bars: 50 μm. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001; \*\*\*\*p \< 0.0001. Data are represented as mean ± SEM.](nihms-1586763-f0005){#F4}

###### 

KEY RESOURCES TABLE

  REAGENT or RESOURCE                                                                      SOURCE                                           IDENTIFIER
  ---------------------------------------------------------------------------------------- ------------------------------------------------ ------------------------------------------------------------------------------
  Antibodies                                                                                                                                
  Mouse monoclonal anti-β-catenin                                                          BD Biosciences                                   Cat\# 610153; RRID: AB_397554
  Rabbit polyclonal anti-β-catenin                                                         Abcam                                            Cat\# ab16051; RRID: AB\_ 443301
  Chicken polyclonal anti-GFP                                                              Aves Labs                                        Cat\# GFP-1020; RRID: AB_10000240
  Rabbit monoclonal anti-Caspase-3, Active Form                                            BD Biosciences                                   Cat\# 559565; RRID:AB_397274
  Mouse monoclonal anti p-96/Dab2                                                          BD Biosciences                                   Cat\# 610464; RRID:AB_397837
  Rabbit polyclonal anti-Akr1b7                                                            Dr Pierre Val and Dr Antoine Martinez; ([@R1])   N/A
  Rabbit polyclonal anti-Gαq                                                               Abcam                                            Cat\# ab75825; RRID:AB_1925009
  Rabbit polyclonal anti-AS                                                                Dr. Celso E. Gomez-Sanchez; ([@R18])             N/A
  Rabbit monoclonal anti-Ki67                                                              Lab Vision                                       Cat\# RM-9106; RRID:AB_2335745
  Rabbit monoclonal anti-Lef1                                                              Abcam                                            Cat\# ab137872
  Rabbit polyclonal anti-Phospho-(Ser/Thr) PKA Substrate                                   Cell Signaling Technology                        Cat\# 9621; RRID:AB_330304
  Rabbit monoclonal anti-β-catenin(ex3)                                                    Abcam                                            Cat\# ab32572; RRID:AB_725966
  Rabbit polyclonal anti-PDE2A                                                             Proteintech                                      Cat\# 55306-1-AP; RRID:AB_11182279
  Donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 647   Molecular Probes                                 Cat\# A-31573; RRID:AB_2536183
  Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 594                Thermo Fisher Scientific                         Cat\# A32742; RRID:AB_2762825
  Goat anti-Chicken IgY (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 488      Thermo Fisher Scientific                         Cat\# A32931; RRID:AB_2762843
  Rabbit polyclonal anti-β-catenin                                                         Cell Signaling Technology                        Cat\# 9581; RRID:AB_490891
  Rabbit polyclonal anti-Histone H3                                                        Abcam                                            Cat\# ab1791, RRID:AB_302613
  Chemicals, Peptides, and Recombinant Proteins                                                                                             
  Angiotensinogen 1-14 renin substrate porcine                                             Sigma Aldrich                                    Cat\# SCP0021-1MG
  Critical Commercial Assays                                                                                                                
  Direct-zol RNA Miniprep                                                                  Zymo Research                                    Cat\# R2051
  High-Capacity cDNA Reverse Transcription Kit                                             Thermo Fisher Scientific                         Cat\# 4368814
  TaqMan Universal PCR Master Mix                                                          Thermo Fisher Scientific                         Cat\# 4364338
  Click-iT Plus TUNEL Assay for *In Situ* Apoptosis Detection, Alexa Fluor 488 dye         Thermo Fisher Scientific                         Cat\# C10617
  Aldosterone RIA (CT)                                                                     Tecan                                            Cat\# MG13051
  Angiotensin I (PRA) RIA (CT)                                                             Tecan                                            Cat\# 30120823
  High-Sensitivity ChIP Kit                                                                Abcam                                            Cat\# ab185913
  Power SYBR Green PCR Master Mix                                                          Thermo Fisher Scientific                         Cat\# 4367659
  Experimental Models: Organisms/Strains                                                                                                    
  Mouse: AS-Cre: 129-Cyp11b2^tm1.1(cre)Brlt/+^                                             Our lab([@R18])                                  N/A
  Mouse: Ctnnb1^flox(ex3)/+^: 129-Ctnnb1^tm1Mmt/+^                                         [@R21]                                           MGI:1858008
  Mouse: mTmG: 129-Gt(ROSA)^26Sortm4(ACTΒ-tdTomato,-EGFP)Luo/J/+^                          The Jackson Laboratory                           JAX:007576
  Oligonucleotides                                                                                                                          
  See [Table S1](#SD1){ref-type="supplementary-material"} for all oligos and primers.                                                       N/A
  Software and Algorithms                                                                                                                   
  Prism v8.3.0                                                                             Graphpad                                         <https://www.graphpad.com/scientific-software/prism/>
  Fiji                                                                                     [@R44]                                           <https://fiji.sc/>
  LIS-Elements Nikon                                                                       Nikon                                            <https://www.microscope.healthcare.nikon.com/products/software/nis-elements>

###### HIGHLIGHTS

-   β-catenin activation drives adrenal hyperplasia by blocking cellular differentiation

-   Upregulation of Pde2a, an inhibitor of cAMP/PKA, is a potential mechanism for the block

-   Hyperplasia is exacerbated by trophic factor stimulation leading to organomegaly
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